Andrew Stevenson, GCMI Executive Director, will be attending the 2019 Healthcare Information and Management Systems Society (HIMSS) Global Conference & Exhibition on February 11–15 in Orlando to discuss GCMI’s “A1” accelerator program. Martin Entwistle, Ares Health Systems CEO, will also be accompanying Andrew to this conference. Ares Health Systems was the first digital health startup to enter GCMI’s accelerator program with the Mpower platform.

Mpower aims to transform healthcare management and close the gap between physician visits by generating, interpreting, and delivering patient data outside of the care setting. Martin will be presenting a demo of the Mpower app at HIMSS 2019. This demo will take place at Booth 509 on Tuesday, February 12.

“There is no shortage of apps and data sources of potential value to patient care, but most remain disconnected from clinical management workflows,” explained Entwistle.

HIMSS aims to transform and remedy the shortcomings that still exist in the healthcare industry through information and innovative technology similar to Mpower.

The HIMSS Global Conference & Exhibition is regarded as the leading health information and technology conference in the industry, bringing together over 45,000 professionals from across the world. This conference focuses on the education, innovation, and collaboration of healthcare professionals to transform health through information and technology.

GCMI is also looking forward to visiting the Israeli Innovation Pavilion at HIMSS, with more than 29 Israeli companies featuring digital health solutions. Through GCMI’s partnership with Rambam Health Care Campus, the largest medical center in northern Israel, GCMI has established a medical technology accelerator for Israeli-based companies. GCMI recognizes the unique medtech innovation produced by Israeli companies and is proud to provide a source of funding and U.S. commercialization pathway expertise to promising Israeli medtech startups.

If you would like to schedule a meeting with GCMI at 2019 HIMSS to learn about our commercialization pathway experience, please send an email to Andrew Stevenson or contact us today.